About this trial
The goal of this observational study is to learn how daily emotional stress affects cognitive function and inflammation in community-dwelling older adults aged 60 and older in Seoul, Republic of Korea. The main questions it aims to answer are:
Does daily psychological stress measured in real-time affect short-term and long-term cognitive function in older adults? Do pro-inflammatory cytokines (such as CRP, IL-6, IL-10, and TNF-α) mediate the relationship between emotional stress and cognitive decline? How do social support and social isolation influence cognitive function and inflammatory biomarkers over time?
Participants will:
Complete baseline surveys assessing depression, cognitive function, and personal characteristics Use a smartphone app to answer brief surveys about their emotions, cognitive performance, and social interactions 1-6 times daily for two weeks Wear a Galaxy Watch to track sleep quality, heart rate, and physical activity Provide blood samples for inflammatory biomarker analysis Return for follow-up assessments at 6 months and 1 year
This study is part of an international collaboration to establish a Korean cohort comparable to the U.S. Einstein Aging Study, with the aim of developing culturally tailored dementia prevention strategies.
Eligibility criteria
Qualifiers
Adults aged 60 or older residing in the Republic of Korea
Samsung Galaxy smartphone users capable of using smartphone applications
Sufficient cognitive ability to understand and follow research instructions (MMSE score of 21 or above)
For individuals who do not meet the cognitive criteria, those who understand the study procedures and provide informed consent along with their legal guardian
Disqualifiers
Diagnosis of dementia at baseline
Severe visual or hearing impairments that prevent participation in psychological assessments
Illiteracy that prevents participation in cognitive testing
Less than 80% compliance with the 2-day preliminary EMA protocol (one additional attempt allowed after re-training)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Korea University
Lead sponsor
Korea University Anam Hospital
Collaborator
Penn State University
Collaborator
Albert Einstein College of Medicine
Collaborator